Target intelligence / Profile preview

Ribosomal protein SA pseudogene 23 (RPSAP23)

Target
RPSAP23
Molecular classification
Other (pseudogene; not an enzyme, receptor, transporter, transcription factor, etc.)
01

Overview

Ribosomal protein SA pseudogene 23 (RPSAP23) is one of several processed pseudogenes derived from the ribosomal protein SA (RPSA) gene, which encodes a multifunctional ribosomal protein that also serves as a laminin receptor in humans[3][5][7]. Pseudogenes such as RPSAP23 typically result from retrotranspositional events and lack the capacity to produce functional proteins. While the full-length RPSA protein is involved in ribosome structure and has roles in cell surface interactions relevant to cancer progression and infective mechanisms, the pseudogene RPSAP23 does not have a confirmed biological function, is not a therapeutic target, and is not associated with known disease phenotypes or drug interactions[3][5][7]. Most research on RPSA pseudogenes focuses on their potential regulatory roles as non-coding RNAs, but there is no evidence that RPSAP23 is functionally significant. In summary: RPSAP23 is not a functional target, receptor, or protein; it is a non-coding pseudogene with no established clinical or biological role[5][7].

Other names
RPSA_5_268RPSAP23
02

Mechanism of action

None

03

Biological functions

None known for the pseudogene itself; functional RPSA participates in protein synthesis and laminin receptor activity, but pseudogenes typically lack biological function
04

Disease associations

None established for RPSAP23; functional RPSA is implicated in cancer and prion diseases, but not the pseudogenes

Beyond the preview

Go deeper on Ribosomal protein SA pseudogene 23 (RPSAP23).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein SA pseudogene 23 (RPSAP23).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call